Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-009663
Filing Date
2019-04-02
Accepted
2019-04-02 19:57:46
Documents
1
Period of Report
2019-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4228
  Complete submission text file 0000899243-19-009663.txt   5750
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NOVELION THERAPEUTICS INC. 1800-510 WEST GEORGIA STREET VANCOUVER A1 V6B OM3
Business Address
Stewart Murray (Reporting) CIK: 0001723450 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 19727165